Enclosed is the investor presentation.

August 5, 2026 BSE Limited National Stock Exchange of India Limited The Listing Department The Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, G Block, 25th Floor, Dalal Street Bandra Kurla Complex Fort, Mumbai 400 001 Bandra (East), Mumbai 400051 Maharashtra, India Maharashtra, India BSE Scrip Code: 544309 NSE Symbol: IKS Dear Sir/Ma’am, Sub: Investor Presentation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith investor presentation on the financial results of the Company for the quarter ended June 30, 2026. The said presentation is also being uploaded on the website of the Company at the https://ikshealth.com/investor-relations/ Request you to take it on record and disseminate the same on your website. Thanking you. Yours sincerely, For Inventurus Knowledge Solutions Limited Sameer Chavan Company Secretary and Compliance Officer Membership No. F7211 Encl: As above Inventurus Knowledge Solutions Limited Registered Address: 801, Building No. 5, 8th Floor, Mindspace Business Park (SEZ), Thane-Belapur Road, Airoli, Navi Mumbai – 400708, Thane, Maharashtra, India Ph.: +91 22 3071 1100 | W: www.ikshealth.com | CIN: L72200MH2006PLC337651 IKS Health Q1 FY 27 Investor Presentation Disclaimer This presentation may include opinions and assumptions about future performance which could be considered as forward-looking statements. Forward-looking statements intrinsically cover several risks and uncertainties, which may lead to a material difference between actual results and the statements themselves. Such statements comprise the company’s current visibility on market movements, client discussions, and related factors. Inventurus Knowledge Solutions Limited does not assume an obligation to update or revise any forward-looking statements. IKS Health - a comprehensive healthcare enablement platform empowering provider organizations US$260bn / US$5tn US$34bn 8% / 12% Total TAM / Outsourced Market US Healthcare TAM / Outsourced Market Addressable Expenditure (CY2024) CAGR (2023-2028E) (CY2023) Market1,2 The only Comprehensive platform that delegates all chores 5+ Years across the patient 600+/650+ 85%+ Top 10 / Top 5 Clients journey Healthcare Organizations Revenues from Repeat Average Vintage Established Q1 27/Q1 26 Customers (As of Mar 31, 2026) Adding a Client technology-enabled Relationships layer to ‘care delivery pyramid’ to help Physician Enterprises 12,889 / 1,902 565 57 achieve optimized revenue and Employees / Clinically Technology Focused Sales & Marketing reduced expenses trained staff Employees Employees Specialised (As of June 30, 2026) (As of June 30, 2026) (As of June 30, 2026) workforce Note: Numbers Rounded off to nearest Integer / percent; 1. Source: Zinnov Report; 2. TAM- Total Addressable Market for RCM, VBC, Patient, Coding and Client Services. 3. Repeat clients refers to 33 clients who availed our platform or solutions during the previous period, and revenue generated from such clients are calculated for the relevant period IKS Health: 5 strategic pillars of execution Integrated System of Action Proprietary models driven Drive growth momentum Get back to optimized Culture and leadership (SOA) & System of Record comprehensive System of through re-stratified key margins through operating (SOR) for rural/ community Action with API integration growth levers model transformation and health system market for large medical group synergies market ● Create the structured unified data ● Translate the trained agentic ● Pick up land and expand (cross sell) ● Evolve from Tech led, HITL to ● Continue to institutionalize an moat for AI training (5MM+ workflows from Rural/ Community momentum in installed base of Autonomy through explainable AI outcome driven culture and longitudinal records) that enable our settings to the large group and Large Health Systems for non-deterministic outcomes operating model to enable outcome SLM’s ambulatory settings and vice versa ● Cross sell System of Action (SOA) in ● Execute Operating model based deals ● Train our proprietary SLM’s that ● Build API-powered integration with the Rural/ Community (TruBridge) Transformation in TruBridge RCM & ● Consolidated Leadership team power the interconnected relevant EHRs installed base Coding Businesses leveraging complementary workflows leveraging the above AI ● Embody Explainability for ● Platform sales in mid-size Health ● Realize Operating and SG&A strengths and capabilities Training moat Generative AI and HITL where Systems / Medical Groups Synergies ● One Unified Culture based on ● Build explainability in each of the applicable intentional manifest of value Generative AI driven workflows; and ● Continue to pursue feature-based behaviors empower with human-in-the-loop KLAS leadership while (HITL) and/or Rules-based AI for demonstrating interconnected end deterministic outcomes to end agentic workflows (platform ● Embed the SOA agentic workflows in capabilities) the native SOR (Electronic Health Record - EHR) workflows Awards and Recognition US Patent US 12,619,923 2 for Engagement Learning Engine AI-driven “Awareness-Ability-Willingness” (AAW) behavioral modeling powers IKS Health’s patient access solutions including MyCareHub which enhance patient engagement and optimize patient scheduling. 2026 Dallas-Fort Worth Titan 100 Titan CEO - Sachin K. Gupta, Founder & Global CEO Best CFO & Finance Strategy Excellence Awards 2026 1. Excellence in Investor Relations (Organisational category) 2. Best CFO in Healthcare – Nithya Balasubramanian, Whole-time Director & Group CFO (Individual category) Awards and Recognition FE HR Awards 2026 Excellence in Onboarding & Role Enablement American Medical Group Association (AMGA) Distinguished Corporate Partner Award 2026 Axia Women’s Health IKS Health partnership for medical coding delivered $12 Million in annual cash impact with 96%+ coding accuracy and 37% lower coding related denials IKS Health enables care transformation across the patient journey Pre-visit Optimized Scheduling Patient Financial Patient Engagement Prospective Clinical Clearance Hub Chart Reviews Peri-visit Legend Autonomous Referral Order IKS ScribbleTM Pre-Visit Coding Management Summary Automation Level Post-visit 1 2 3 4 5 Billing and Denial Payment Posting and Denial Concurrent and Patient AR Management Prevention Management Denovo Risk Coding Fully Fully Manual Autonomous between visits Care Management Inbox IKS AssuRxTM IKS StacksTM and UM Management In-acute settings Clinical Documentation Clinical Coding Revenue Optimization Medico-legal Discharge Solutions And CDI Solutions Documentation Solutions Summary Q1 - Strong growth while delivering continuous margin expansion Deep Client Strong Margin Globally Diversified Growth At Scale Relationships Profile Workforce 450+ 12,889 INR 8,936 mn EBITDA Enterprise level (in spite of Total Employees Revenue from one-time acquisition costs) customers Operations 21% INR mn 3,759 22% 1,902 / 565 YoY growth in INR Revenue from Top 10 PAT Margin Clinical /tech customers focussed employees 12% 5.76 / 7.41 years 24%/28% YoY growth in USD Top 10 / Top 5 Clients YoY growth in Women employees Average Vintage EBITDA/PAT Q1 FY 27: Growing faster than market with strong margins Revenue EBITDA INR Mn INR Mn 3,002 2,949 24.0% YoY (even higher 8,936 8,577 if not for one-time 2,378 20.7% YoY 7,401 acquisition costs) 33.0% 35.0% 1.8% QoQ (due to 32.1% one-time acquisition 4.2% QoQ costs and reduction in currency gains) Q1 FY26 Q4 FY26 Q1 FY27 Q1 FY26 Q4 FY26 Q1 FY27 PAT Adjusted PAT* INR Mn INR Mn 2,269 2,153 2,060 1,937 27.8% YoY 28.0% YoY 1,515 1,682 21.7% 24.1% 24.0% 26.5% 5.9% QoQ 5.1% QoQ 20.5% 22.7% Q1 FY26 Q4 FY26 Q1 FY27 Q1 FY26 Q4 FY26 Q1 FY27 *Adjusted PAT is adjusted for amortization of intangible assets recognised on acquisition which is a non-cash expense. Q1 FY 27 - Continued strong cash generation supporting [Showing first 8,000 characters — download PDF for full document]